FDA inspection

Rommelag CDMO GmbH: FDA inspection ending Mar 20, 2025

FDA inspection 1332822 · Voluntary Action Indicated (VAI) · Sulzbach-Laufen

Key facts

Inspection ID 1332822
Firm Rommelag CDMO GmbH
FEI number 3002808845
City Sulzbach-Laufen
Country Germany
Fiscal year 2025
Inspection end date Mar 20, 2025
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections